CCN5 and breast adenocarcinoma: CCN5 TSP1 induced expression of estrogen receptor-α in triple negative MDA-MB-231 mammary adenocarcinoma cells and inhibited epithelial-to-mesenchymal transition (EMT) in the same cells.